Want to see AU:ALA full AI Analyst Report?
Arovella Therapeutics Limited (ALA) Ownership - Who Owns Arovella Therapeutics Limited?
Arovella Therapeutics Limited (ALA) Ownership Overview
- 0.28% Insiders
- 99.72% Public Companies and Individual Investors
The ownership structure of Arovella Therapeutics Limited (AU:ALA) stock is a mix of institutional, retail, and individual investors. , 0.28% is owned by Insiders, and 99.72% is owned by Public Companies and Individual Investors.
The ownership structure of Arovella Therapeutics Limited (AU:ALA) stock is a mix of institutional, retail, and individual investors. , 0.28% is owned by Insiders, and 99.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 09, 2026 | David Williams | AU$13,400 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Elizabeth Stoner | 1,920,804 | Insider | 0.16% | 71,070 |
| Debora Barton | 1,276,490 | Insider | 0.11% | 47,230 |
| David Williams | 200,000 | Insider | 0.02% | 7,400 |
FAQ
What percentage of Arovella Therapeutics Limited (AU:ALA) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.72% of Arovella Therapeutics Limited (AU:ALA) stock is held by public companies and individual investors.
Who owns the most shares of Arovella Therapeutics Limited (AU:ALA)?
Elizabeth Stoner owns the most shares of Arovella Therapeutics Limited (AU:ALA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.